Industry News's blog

DMCA.com Protection Status
Industry News's picture
Keywords: 

Industry News

Toronto, CANADA – (August 11, 2022) MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for the detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DX™ devices. Leonard Kofman and Jody Staggs, Managing Director of SWK Holdings will join MolecuLight's Board of Directors as observers.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Leeds, UK and Toronto, CANADA – (July 13, 2022) MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for the detection of wounds containing elevated bacterial loads, announced the publication of an independent, blind randomized controlled trial in Diabetes Care. The publication on this 56-patient trial, titled “The use of Point-of-Care Bacterial Autofluorescence Imaging in the Management of Diabetic Foot Ulcers: A Pilot Randomized Controlled Trial”1 reported that the use of a MolecuLight i:X® device to visualize the presence of elevated bacterial burden in wounds doubled 12-week wound healing rates (204%) in diabetic foot ulcer patients over standard-of-care alone.

Blog Category: 
Industry News's picture
Keywords: 

Industry News

TORONTO, CANADA – (July 7, 2022) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that it has been selected for a “Top Innovation in Wound Care 2022” Award from Wound Management & Prevention (WMP) Journal for its MolecuLightDX™ device.

Blog Category: 
Industry News's picture
Keywords: 

By Industry News

Sarasota, FL – (June 29, 2022) – As sales and production of advanced wound care treatments ramp up, Omeza hired 5 more team members. Initial sales of Omeza® Collagen Matrix Rx, Omeza® Lidocaine Lavage and Omeza® Skin Protectant to Veterans Administration facilities were logged in June with 1 reorder last week.

Blog Category: 
Industry News's picture
Keywords: 

Industry News

Lafayette, LA – (July 5, 2022) Biologics company Tides Medical® announces the launch of a new product, Artacent AC®, a tri-layer skin graft designed for use in the treatment of complex or difficult-to-treat wounds.

Blog Category: 
Industry News's picture
Keywords: 

Industry News

TORONTO, CANADA – (June 29, 2022) MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for the detection of wounds containing elevated bacterial loads, announces that it has received an expansion to its FDA 510(k) clearance for the MolecuLighti:X® imaging device’s ability to detect the location of elevated bacterial loads (>104 CFU/g) in wounds. The expanded labelling also includes the device’s ability to identify areas of wounds containing more bacterial species, including key target pathogens of interest to the CDC that are major causes of antimicrobial resistance. Detectable species include gram-negative and gram-positive species, aerobes and anaerobes. This expanded labeling is based on a detailed retrospective statistical analysis of over 350 patients.

Blog Category: 
Industry News's picture
Keywords: 

Industry News

McDonough, GA, – (June 2022) – Encompass Group, LLC is bringing its line of eMax® Replacement Support Surfaces to the acute care market.

Blog Category: 
Industry News's picture
Keywords: 

Industry News

PITTSBURGH, PA – (June 14, 2022) MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for the detection of bacteria in wounds, announces it has been awarded a new group purchasing agreement with Premier, Inc. – a leading health care improvement company, uniting an alliance of more than 4,400 U.S. hospitals and 225,000 other providers. The MolecuLight i:X® and DX™ wound imaging devices were also awarded Premier’s Technology Breakthrough designation signifying innovative products that are helping clinicians to improve the state of wound care and ultimately to improve outcomes.

Blog Category: 
Industry News's picture

By Industry News

Toronto, CANADA and London, UK – (June 1, 2022) MolecuLight Inc., a manufacturer in point-of-care fluorescence imaging for detection of elevated bacterial load in wounds, announced that it has been added to the new 2022 Consensus Guidelines of the International Surgical Wound Complications Advisory Panel (ISWCAP). The document, “Optimising Prevention of Surgical Wound Complications: Detection, Diagnosis, Surveillance and Prediction”1 presents an international consensus recommending approaches for the early detection, diagnosis, and prediction of surgical wound complications in order to optimize incisional wound healing outcomes for patients.

Industry News's picture
Keywords: 

By Industry News

JACKSONVILLE, Fla., May 10, 2022Next Science Limited reports that XPERIENCETM No Rinse Solution has been shown to have persistent efficacy against both planktonic bacteria and bacterial biofilms in a new study published in The Journal of Arthroplasty.

Blog Category: 

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.